Effect of Cholesterol Lowering on the Progression of Aortic Stenosis in Patients With Mild to Moderate Aortic Stenosis (ASTRONOMER) Aortic Stenosis Progression Observation Measuring Effects of Rosuvastatin and The Sub-Study Protocol

Trial Profile

Effect of Cholesterol Lowering on the Progression of Aortic Stenosis in Patients With Mild to Moderate Aortic Stenosis (ASTRONOMER) Aortic Stenosis Progression Observation Measuring Effects of Rosuvastatin and The Sub-Study Protocol

Completed
Phase of Trial: Phase III

Latest Information Update: 07 Sep 2015

At a glance

  • Drugs Rosuvastatin (Primary)
  • Indications Aortic valve stenosis
  • Focus Registrational; Therapeutic Use
  • Acronyms ASTRONOMER
  • Sponsors AstraZeneca
  • Most Recent Events

    • 07 Sep 2015 Results published in the Journal of the American College of Cardiology.
    • 17 Jul 2012 Predefined substudy results published in the Journal of the American College of Cardiology.
    • 09 Apr 2010 Results reported in the 59th Annual Scientific Session of the American College of Cardiology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top